First-Line (1L) Systemic Therapy in Patients (pts) with Advanced Non-Small Cell Lung Cancer (aNSCLC) at Community Settings in the United States (US)
07:30am - 03:45pm EDT - April 1, 2023
07:30am - 03:45pm EDT - April 1, 2023
Author(s):
- Dr. Pragya Rai, PhD, Associate Director, Outcomes Research, Merck & Co., Inc.
Tags: Outcomes and Health Services Research
| Display Label | Action |
|---|---|
| W4332723-NCCN_Poster_1L_aNSCLC_raiprag_v1.08.pdf | Download Handout |